These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14680468)

  • 1. Parvovirus vectors for cancer gene therapy.
    Ponnazhagan S
    Expert Opin Biol Ther; 2004 Jan; 4(1):53-64. PubMed ID: 14680468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer gene therapy through autonomous parvovirus--mediated gene transfer.
    Cornelis JJ; Lang SI; Stroh-Dege AY; Balboni G; Dinsart C; Rommelaere J
    Curr Gene Ther; 2004 Sep; 4(3):249-61. PubMed ID: 15384939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of the use of autonomous parvovirus-based vectors.
    Dupont F
    Curr Gene Ther; 2003 Dec; 3(6):567-82. PubMed ID: 14683452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.
    Paglino JC; Andres W; van den Pol AN
    J Virol; 2014 May; 88(9):4932-42. PubMed ID: 24554651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vectors based on autonomous parvoviruses: novel tools to treat cancer?
    Cornelis JJ; Salomé N; Dinsart C; Rommelaere J
    J Gene Med; 2004 Feb; 6 Suppl 1():S193-202. PubMed ID: 14978762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomous parvovirus vectors.
    Maxwell IH; Terrell KL; Maxwell F
    Methods; 2002 Oct; 28(2):168-81. PubMed ID: 12413415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.
    Berns KI; Srivastava A
    Gastroenterol Clin North Am; 2019 Jun; 48(2):319-330. PubMed ID: 31046978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvoviral vectors for the gene therapy of cancer.
    Shaughnessy E; Lu D; Chatterjee S; Wong KK
    Semin Oncol; 1996 Feb; 23(1):159-71. PubMed ID: 8607026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
    Brandenburger A; Velu T
    J Gene Med; 2004 Feb; 6 Suppl 1():S203-11. PubMed ID: 14978763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice.
    Hendrie PC; Hirata RK; Russell DW
    J Virol; 2003 Dec; 77(24):13136-45. PubMed ID: 14645570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.
    Fakhiri J; Grimm D
    Mol Ther; 2021 Dec; 29(12):3359-3382. PubMed ID: 33831556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.
    Dinsart C; Pervolaraki K; Stroh-Dege A; Lavie M; Ronsse I; Rommelaere J; Van Damme J; Van Raemdonck K; Struyf S
    Hum Gene Ther; 2017 Mar; 28(3):295-306. PubMed ID: 28042949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters.
    Maxwell IH; Spitzer AL; Long CJ; Maxwell F
    Gene Ther; 1996 Jan; 3(1):28-36. PubMed ID: 8929909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsidation of a recombinant LuIII parvovirus genome by H1 virus and the fibrotropic or lymphotropic strains of minute virus of mice.
    Maxwell IH; Long CJ; Carlson JO; Rhode SL; Maxwell F
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1175-9. PubMed ID: 8509766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant adeno-associated virus vectors for gene therapy.
    Conlon TJ; Flotte TR
    Expert Opin Biol Ther; 2004 Jul; 4(7):1093-101. PubMed ID: 15268676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin.
    Olijslagers S; Dege AY; Dinsart C; Voorhoeve M; Rommelaere J; Noteborn MH; Cornelis JJ
    Cancer Gene Ther; 2001 Dec; 8(12):958-65. PubMed ID: 11781658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of DNA viruses as vectors for gene therapy.
    Ali M; Lemoine NR; Ring CJ
    Gene Ther; 1994 Nov; 1(6):367-84. PubMed ID: 7584103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
    Moehler M; Blechacz B; Weiskopf N; Zeidler M; Stremmel W; Rommelaere J; Galle PR; Cornelis JJ
    Cancer Gene Ther; 2001 Mar; 8(3):158-67. PubMed ID: 11332986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
    El Bakkouri K; Servais C; Clément N; Cheong SC; Franssen JD; Velu T; Brandenburger A
    J Gene Med; 2005 Feb; 7(2):189-97. PubMed ID: 15515141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of parvovirus LuIII NS1 from a Sindbis replicon for production of LuIII-luciferase transducing virus.
    Corsini J; Maxwell IH; Maxwell F; Carlson JO
    Virus Res; 1996 Dec; 46(1-2):95-104. PubMed ID: 9029782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.